Literature DB >> 5312998

Immunization against neonatal tetanus in New Guinea.

M C Hardegree, M F Barile, M Pittman, F D Schofield, R Maclennan, A Kelly.   

Abstract

THIS PAPER DESCRIBES: (1) a continuation of the study reported in 1965 of tetanus antitoxin titres among women after primary immunization with plain, AlPO(4)-adsorbed or oil adjuvant toxoids; (2) the effect of age and of abscess formation due to oil adjuvants on antitoxin response; and (3) a comparative study of titres in some women of the study groups who received either a plain or an AlPO(4) toxoid booster injection in pregnancy.The results support our previous recommendation to use aluminium adjuvant toxoid in the prevention of neonatal tetanus. Mean maternal protective antitoxin levels were maintained for 40 months but not for 54 months after 2 primary injections and booster response was higher in those immunized with this toxoid than in those immunized with plain toxoid. Also, the use of AlPO(4) toxoid as booster stimulated a higher antitoxin response than did the use of plain toxoid. Mean protective levels induced by oil adjuvant toxoids (1 injection) persisted for the same time as for the adsorbed toxoid (2 injections). Age did not significantly affect the level of antitoxin response, whereas abscess formation was associated with a higher level.Pregnancy appeared to favour the incidence of antitoxin responders to adsorbed toxoids. Failure to respond to primary immunization with 2 injections of adsorbed toxoid occurred in 7% of women while 100% responded to the oil adjuvant toxoids. Induction of abscess formation precludes use of the latter toxoids, however. Additional studies are needed on the influence of larger antigen doses on the primary response in different ethnic and ecological situations and on the influence of smaller antigen doses on the booster response where repeated booster injections are indicated.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312998      PMCID: PMC2427681     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  19 in total

1.  New approaches to tetanus prophylaxis.

Authors:  S D Rubbo
Journal:  Lancet       Date:  1966-08-27       Impact factor: 79.321

2.  The toxicity of free fatty acids and Arlacel A.

Authors:  M C Hardegree; R L Kirschstein
Journal:  Ann Allergy       Date:  1968-05

3.  Tetanus-toxoid emergency boosters: a reappraisal.

Authors:  T C Peebles; L Levine; M C Eldred; G Edsall
Journal:  N Engl J Med       Date:  1969-03-13       Impact factor: 91.245

4.  Reactions to tetanus toxoid.

Authors:  F J Kittler; P Smith; B F Hefley; A G Cazort
Journal:  South Med J       Date:  1966-02       Impact factor: 0.954

5.  Excessive use of tetanus toxoid boosters.

Authors:  G Edsall; M W Elliott; T C Peebles; M C Eldred
Journal:  JAMA       Date:  1967-10-02       Impact factor: 56.272

6.  Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.

Authors:  M Pittman; R W Kolb; M F Barile; M C Hardegree; E B Seligmann; R Maclennan; F D Schofield
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.

Authors:  M F Barile; M C Hardegree; M Pittman
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

8.  Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids.

Authors:  R MacLennan; F D Schofield; M Pittman; M C Hardegree; M F Barile
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

9.  Differences in palpable liver and spleen rates between men and women of the Sepik District, New Guinea The effects of pregnancy and lactation.

Authors:  F D SCHOFIELD
Journal:  Trans R Soc Trop Med Hyg       Date:  1962-01       Impact factor: 2.184

10.  Influence of antigens on release of free fatty acids from Arlacel A (mannide monooleate).

Authors:  M C Hardegree; M Pittman
Journal:  Proc Soc Exp Biol Med       Date:  1966-10
View more
  7 in total

Review 1.  Vaccines for women for preventing neonatal tetanus.

Authors:  Vittorio Demicheli; Antonella Barale; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2015-07-06

2.  Control of neonatal tetanus.

Authors:  A M Galazka
Journal:  Indian J Pediatr       Date:  1985 Jul-Aug       Impact factor: 1.967

3.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

4.  Immunization against neonatal tetanus in New Guinea. 5. Laboratory assayed potency of tetanus toxoids and relationship to human antitoxin response.

Authors:  M Pittman; R W Kolb; M F Barile; M C Hardegree; E B Seligmann; R Maclennan; F D Schofield
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

5.  Immunization against neonatal tetanus in New Guinea. 3. The toxin-neutralization test and the response of guinea-pigs to the toxoids as used in the immunization schedules in New Guinea.

Authors:  M F Barile; M C Hardegree; M Pittman
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

6.  The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid.

Authors:  R Maclennan; L Levine; K W Newell; G Edsall
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

7.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.